PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding PMV Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 55 | 54 | −1 |
| Shares | 37.3M | 34.7M | −2.64M (−7.1%) |
| Value | $40.7M | $36.8M | −$3.92M (−9.6%) |
New holders (7)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 44,758 | $47.4K | 0.00% |
| Shay Capital LLC | 24,310 | $25.8K | 0.01% |
| HRT Financial LP | 22,437 | $23.0K | 0.00% |
| Pathstone Holdings, LLC | 17,487 | $18.5K | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 8,790 | $9.32K | 0.00% |
| Raymond James Financial Inc | 200 | $212 | 0.00% |
| Simplex Trading, LLC | 71 | $0 | 0.00% |
Sold out (8)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| PFM Health Sciences, LP | 3,301,942 | $3.60M |
| Connor, Clark & Lunn Investment Management Ltd. | 267,636 | $291.7K |
| Jacobs Levy Equity Management, Inc | 129,914 | $141.6K |
| Price T Rowe Associates Inc | 33,600 | $37.0K |
| Ameriprise Financial Inc | 18,007 | $19.6K |
| Wells Fargo & Company | 10,000 | $10.9K |
| Public Employees Retirement System of Ohio | 2,092 | $2.28K |
| FMR LLC | 315 | $343 |